Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 18.
doi: 10.1111/cge.70069. Online ahead of print.

Reanalysis of Whole Genome Sequencing Resolves Genetically Undiagnosed Patients With "RNUopathies"

Shiqi Fan  1   2 , Shuanghao Yang  3 , Xiaojing Nie  4 , Zhihua Yu  5 , Yan Jiang  6 , Miao Sun  1   2 , Weiyue Gu  3 , Xue Zhang  1   2
Affiliations

Reanalysis of Whole Genome Sequencing Resolves Genetically Undiagnosed Patients With "RNUopathies"

Shiqi Fan et al. Clin Genet. .

Abstract

Neurodevelopmental disorders (NDD) are a group of complex conditions characterized by marked phenotypic heterogeneity, primarily involving impairments in cognitive, emotional, and motor development. Approximately 40%-60% of patients with rare NDD remain genetically undiagnosed. Recently, RNU2-2 and RNU5B-1 have been identified as novel genes underlying the "RNUopathies" a syndromic NDD caused by variants in non-coding spliceosomal genes. In this study, we aimed to focus on RNU2-2 and RNU5B-1 by analyzing the whole-genome sequencing (WGS) data from 18326 Chinese individuals (including 2970 trios and 9416 samples without parental data), among whom 4900 had confirmed NDD phenotypes. Reanalysis of WGS data solved the previously undiagnosed cases of four patients with NDD carrying de novo variants in RNU genes, including three patients carrying the RNU2-2 variants (two cases with n.4G>A and one case with n.35A>G), and one case with an unreported RNU5B-1 variant (n.38C>T). In this study, detailed phenotypic elaboration and comparison with previous studies help clinicians in more effective diagnosis of NDD and underscore the importance of reanalyzing negative genetic data, which deepens our understanding of the "RNUopathies."

Keywords: major spliceosome; neurodevelopmental disorders; noncoding genes; small nuclear RNA; whole‐genome sequencing.

PubMed Disclaimer

References

    1. I. Parenti, L. G. Rabaneda, H. Schoen, and G. Novarino, “Neurodevelopmental Disorders: From Genetics to Functional Pathways,” Trends in Neurosciences 43, no. 8 (2020): 608–621.
    1. C. F. Wright, P. Campbell, R. Y. Eberhardt, et al., “Genomic Diagnosis of Rare Pediatric Disease in the United Kingdom and Ireland,” New England Journal of Medicine 388, no. 17 (2023): 1559–1571.
    1. D. Greene, C. Thys, I. R. Berry, et al., “Mutations in the U4 snRNA Gene RNU4‐2 Cause One of the Most Prevalent Monogenic Neurodevelopmental Disorders,” Nature Medicine 30 (2024): 2165–2169.
    1. R. Schot, F. Ferraro, G. Geeven, K. E. M. Diderich, and T. S. Barakat, “Re‐Analysis of Whole Genome Sequencing Ends a Diagnostic Odyssey: Case Report of an RNU4‐2 Related Neurodevelopmental Disorder,” Clinical Genetics 106, no. 4 (2024): 512–517.
    1. Y. Chen, R. Dawes, H. C. Kim, et al., “De Novo Variants in the RNU4‐2 snRNA Cause a Frequent Neurodevelopmental Syndrome,” Nature 632 (2024): 832–840.

LinkOut - more resources